Nathalie Neveux

Nathalie Neveux

Auto-generated profile, based on publicly available information

Nathalie Neveux

Immunomodulatory Therapies Multidisciplinary Study Group (CERTIM), Paris, France; Department of Medical Biology, Cochin Hospital, AP-HP, Paris, France

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Clinical Nutrition
Verified
Journal Article
Closed access
SDSarah Dellière
Sarah Dellière
LPLydia Pouga
Lydia Pouga
NNNathalie Neveux
Nathalie Neveux
AHAlain Hernvann
Alain Hernvann
Jean Pascal De BandtJean Pascal De Bandt
Jean Pascal De Bandt
LCLuc Cynober
Luc Cynober

17 June 2021 in Maternal & Child Nutrition
Verified
Journal Article
Open access
PDF file
Violeta Moya-AlvarezVioleta Moya-Alvarez
Violeta Moya-Alvarez
JKJean‐Christophe Junior Koyembi
Jean‐Christophe Junior Koyembi
LKLaure M. Kayé
Laure M. Kayé
JMJean‐Robert Mbecko
Jean‐Robert Mbecko
HSHugues Sanke-Waïgana
Hugues Sanke-Waïgana
BMBenoit Marteyn
Benoit Marteyn
In the MITICA (Mother‐to‐Infant TransmIssion of microbiota in Central‐Africa) study, 48 mothers and their 50 infants were followed from delivery to 6 months between December 2017 and June 2019 in Bangui (Central‐African Republic). Blood tests and stool analyses were performed in mothers at delivery, and their offspring at birth, 11 weeks and 25 weeks. Stool cultures were performed in specific growth media for Salmonella, Shigella, E. coli, Campylobacter, Enerobacter, Vibrio cholerae, Citrobacter and Klebsiella, as well as rotavirus, yeasts and parasitological exams. The median vitamin C levels in mothers at delivery were 15.3 μmol/L (inter‐quartile‐range [IQR] 6.2–27.8 μmol/L). In infants, the median vitamin C levels at birth were 35.2 μmol/L (IQR 16.5–63.9 μmol/L). At 11 and 25 weeks, the median vitamin C levels were 41.5 μmol/L (IQR 18.7–71.6 μmol/L) and 18.2 μmol/L (IQR 2.3–46.6 μmol/L), respectively. Hypovitaminosis C was defined as seric vitamin C levels <28 μmol/L and vitamin C deficiency was defined as vitamin C levels <11 μmol/L according to the WHO definition. In mothers, the prevalence of hypovitaminosis‐C and vitamin C deficiency at delivery was 34/45 (75.6%) and 19/45 (42.2%), respectively. In infants, the prevalence of hypovitaminosis‐C and vitamin C deficiency at 6 months was 18/33 (54.6%) and 11/33 (33.3%), respectively. Vitamin C levels in mothers and infants were correlated at birth (Spearman's rho = 0.5; P value = 0.002), and infants had significantly higher levels of vitamin C (median = 35.2 μmol/L; IQR 16.5–63.9 μmol/L), compared to mothers (median = 15.3 μmol/L; IQR 6.2–27.8 μmol/L; P value <0.001). The offspring of vitamin C‐deficient mothers had significantly lower vitamin C levels at delivery (median = 18.7 μmol/L; IQR 13.3–30.7 μmol/L), compared to the offspring of non‐deficient mothers (median = 62.2 μmol/L; IQR 34.6–89.2 μmol/L; P value <0.001). Infants with hypovitaminosis‐C were at significantly higher risk of having a positive stool culture during the first 6 months of life (adjusted OR = 5.3, 95% CI 1.1; 26.1; P value = 0.038).

1 August 2012 in Critical Care Medicine
Verified
Journal Article
Closed access
CBCharlotte Msc Breuillard
Charlotte Msc Breuillard
SDSylviane Darquy
Sylviane Darquy
ECEmmanuel Curis
Emmanuel Curis
NNNathalie Neveux
Nathalie Neveux
JGJean-Pierre Garnier
Jean-Pierre Garnier
Jean Pascal De BandtJean Pascal De Bandt
Jean Pascal De Bandt
Objective: Obese and type 2 diabetic patients present metabolic disturbance–related alterations in nonspecific immunity, to which the decrease in their plasma arginine contributes. Although diabetes-specific formulas have been developed, they have never been tested in the context of an acute infectious situation as can be seen in intensive care unit patients. Our aim was to investigate the effects of a diabetes-specific diet enriched or not with arginine in a model of infectious stress in a diabetes and obesity situation. As a large intake of arginine may be deleterious, this amino acid was given in graded fashion. Design: Randomized, controlled experimental study. Setting: University research laboratory. Subjects: Zucker diabetic fatty rats. Interventions: Gastrostomized Zucker diabetic fatty rats were submitted to intraperitoneal lipopolysaccharide administration and fed for 7 days with either a diabetes-specific enteral nutrition without (G group, n = 7) or with graded arginine supply (1–5 g/kg/day) (GA group, n = 7) or a standard enteral nutrition (HP group, n = 10). Measurements and Main Results: Survival rate was better in G and GA groups than in the HP group. On day 7, plasma insulin to glucose ratio tended to be lower in the same G and GA groups. Macrophage tumor necrosis factor-α (G: 5.0 ± 1.1 ng/2 × 106 cells·hr−1; GA: 3.7 ± 0.8 ng/2 × 106 cells·hr−1; and HP: 1.7 ± 0.6 ng/2 × 106 cells·hr−1; p < .05 G vs. HP) and nitric oxide (G: 4.5 ± 1.1 ng/2 × 106 cells·hr−1; GA: 5.1 ± 1.0 ng/2 × 106 cells·hr−1; and HP: 1.0 ± 0.5 nmol/2 × 106 cells·hr−1; p < .05 G and GA vs. HP) productions were higher in the G and GA groups compared to the HP group. Macrophages from the G and GA groups exhibited increased arginine consumption. Conclusions: In diabetic obese and endotoxemic rats, a diabetes-specific formula leads to a lower mortality, a decreased insulin resistance, and an improvement in peritoneal macrophage function. Arginine supplementation has no additional effect. These data support the use of such disease-specific diets in critically ill diabetic and obese patients.

1 May 2004 in Nutrition
Verified
Journal Article
Closed access
SCSamira Chaı̈b
Samira Chaı̈b
CCChristine Charrueau
Christine Charrueau
NNNathalie Neveux
Nathalie Neveux
CCColette Coudray-Lucas
Colette Coudray-Lucas
LCLuc Cynober
Luc Cynober
Jean Pascal De BandtJean Pascal De Bandt
Jean Pascal De Bandt

1 February 2021 in Clinical Nutrition
Verified
Journal Article
Closed access
FMFrançois Mifsud
François Mifsud
SCSébastien Czernichow
Sébastien Czernichow
CCClaire Carette
Claire Carette
RLRachel Levy
Rachel Levy
PRPhilippe Ravaud
Philippe Ravaud
JBJ.L. Bouillot
J.L. Bouillot

6 September 2024 in Clinical Nutrition ESPEN
Verified
Journal Article
Closed access
MMManuela Tiako Meyo
Manuela Tiako Meyo
PBPascaline Boudou-Rouquette
Pascaline Boudou-Rouquette
JAJennifer Arrondeau
Jennifer Arrondeau
JCJeanne Qiong Yu Chen
Jeanne Qiong Yu Chen
LHLaure Hirsch
Laure Hirsch
FGFrançois Goldwasser
François Goldwasser